Insights

Clinical value Real-time intraoperative fluorescence imaging with AVB-620 offers potential to reduce reoperations in breast-conserving surgery by identifying positive margins that would otherwise require repeat procedures, presenting a high-value target for surgical oncology teams and hospital systems.

Expansion potential Beyond breast cancer, there are clearest near-term opportunities in ovarian, colorectal, head and neck, melanoma, and sarcoma surgeries where real-time tumor visualization could improve margin assessment, enabling cross-specialty adoption within surgical oncology platforms.

Regulatory readiness With ongoing clinical development and a focus on regulatory and quality systems, the company can partner with hospitals and device manufacturers to streamline adoption of the paired fluorescent agent and camera system, accelerating procurement conversations.

Strategic partnerships Avelas can leverage its Nobel-connected origin and deep publication footprint to engage research institutions, academic medical centers, and thinned-down competitors seeking differentiators in image-guided surgery, positioning as a preferred collaborator for trials and co-development.

Financial dynamics Sub-$1M revenue and $42M funding profile indicate early-stage commercialization with needs for strategic pilots and joint development deals that can demonstrate value at scale, motivating reference sites and volume-based pricing discussions with major surgical centers.

Similar companies to Avelas Biosciences, Inc.

Avelas Biosciences, Inc. Tech Stack

Avelas Biosciences, Inc. uses 8 technology products and services including WordPress, MySQL, Shopify, and more. Explore Avelas Biosciences, Inc.'s tech stack below.

  • Content Management System
  • MySQL
    Database
  • E-commerce
  • Infrastructure As A Service
  • jQuery
    Javascript Libraries
  • Platform As A Service
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics

Media & News

Avelas Biosciences, Inc.'s Email Address Formats

Avelas Biosciences, Inc. uses at least 2 email formats:
Avelas Biosciences, Inc. Email FormatsExamplePercentage
FLast@avelasbio.comJDoe@avelasbio.com
73%
Last@avelasbio.comDoe@avelasbio.com
27%

Frequently Asked Questions

What is Avelas Biosciences, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Avelas Biosciences, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Avelas Biosciences, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Avelas Biosciences, Inc.'s official website is avelasbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Avelas Biosciences, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Avelas Biosciences, Inc.'s annual revenue is estimated to be <$1M.

What is Avelas Biosciences, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Avelas Biosciences, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Avelas Biosciences, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Avelas Biosciences, Inc. has approximately 2 employees across 1 continents, including North America. Key team members include President And Chief Executive Officer: C. S. and Controller: J. R. Explore Avelas Biosciences, Inc.'s employee directory with LeadIQ.

What industry does Avelas Biosciences, Inc. belong to?

Minus sign iconPlus sign icon
Avelas Biosciences, Inc. operates in the Biotechnology Research industry.

What technology does Avelas Biosciences, Inc. use?

Minus sign iconPlus sign icon
Avelas Biosciences, Inc.'s tech stack includes WordPress, MySQL, Shopify, Google Cloud, jQuery, WP Engine, PHP and Google Analytics.

What is Avelas Biosciences, Inc.'s email format?

Minus sign iconPlus sign icon
Avelas Biosciences, Inc.'s email format typically follows the pattern of FLast@avelasbio.com. Find more Avelas Biosciences, Inc. email formats with LeadIQ.

How much funding has Avelas Biosciences, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Avelas Biosciences, Inc. has raised $42M in funding. The last funding round occurred on Jun 17, 2019.
Avelas Biosciences, Inc. logo

Avelas Biosciences, Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Avelas Biosciences is a clinical-stage biotechnology company focused on fluorescence imaging to enable real-time cancer detection during surgery. Its lead agent, pegloprastide (AVB-620), is designed to be used with a fluorescence camera system to help visualize cancer during operative procedures and improve surgical precision. The technology utilizes Activatable Cell Penetrating Peptide (ACPP) delivery to target tumors through their biochemistry, a foundation traced to the lab of Nobel Prize laureate Dr. Roger Y. Tsien at UC San Diego.
Based in La Jolla, California, the company operates in the biotechnology research sector and targets oncologic surgery where real-time visualization could affect outcomes. In a prospective study of breast-conserving surgery for primary breast cancer, pegloprastide correctly identified cancer in up to 75% of women with positive margins who would otherwise have required a reoperation, and the company is pursuing additional cancer types such as ovarian, colorectal, head and neck, melanoma, and sarcoma.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
2-10

Section iconFunding & Financials

  • $42M

    Avelas Biosciences, Inc. has raised a total of $42M of funding over 5 rounds. Their latest funding round was raised on Jun 17, 2019 as a Venture Round.

  • <$1M

    Avelas Biosciences, Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.